Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DORM Trial: COVID-19 Prophylaxis in Migrant Workers
NCT04446104Phase 3Completed
- Sponsor
- National University Hospital
- Start
- May 2020
- Primary completion
- Aug 2020
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine, CHILD-IVITAB, zinc, IVIEW-1502 in coronavirus disease 2019 (COVID-19), sponsored by National University Hospital. Started May 2020; status: completed.
02
Drugs
hydroxychloroquineCHILD-IVITABzincIVIEW-1502
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04446104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04446104.